{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:33:39Z","timestamp":1793846019154,"version":"4.6.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Difficulty in providing endoscopy for patients with iron deficiency anaemia (IDA) during the COVID-19 pandemic has highlighted the requirement for a prioritisation tool. We aimed to test the validity of qFIT as a prioritisation tool in patients with iron deficiency and its ability to identify patients with advanced neoplastic lesions (ANLs). Data collected from patients referred with biochemically proven iron deficiency (ferritin \u2264 15 \u03bcg\/L) and synchronous qFIT who underwent full gastrointestinal investigation within NHS Greater Glasgow and Clyde was analysed retrospectively. Patients who did not undergo full investigation, defined as gastroscopy and colonoscopy or CT colonography, were excluded. ANLs were defined as defined as upper GI cancer, colorectal adenoma \u2265 1 cm or colorectal cancer. Area under the curve (AUC) analysis was performed on qFIT results and outcome, defined as the presence of an ANL. AUC analysis guided cut-off scores for qFIT. Patients with a qFIT of &amp;lt;10, 10\u2013200, &amp;gt;200, were allocated a score of 1, 2, and 3, respectively. A total of 575 patients met criteria for inclusion into the study. Overall, qFIT results strongly predicted the presence of ANLs (AUC 0.87, CI 0.81\u20130.92; <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The prevalence of ANLs in patients with scores 1\u20133 was 1.2, 13.5, and 38.9% respectfully. When controlled for other significant variables, patients with a higher qFIT score were statistically more likely to have an ANL (qFIT score = 2; OR 12.8; <jats:italic>P<\/jats:italic> &amp;lt; 0.001, qFIT score = 3, OR 50.0; <jats:italic>P<\/jats:italic> &amp;lt; 0.001). A negative qFIT had a high NPV for the presence of ANLs (98.8%, CI 97.0\u201399.5%). These results strongly suggest that qFIT has validity as a prioritisation tool in patients with iron deficiency; both allowing for a more informed decision of investigation of patients with very low risk of malignancy, and in identifying higher risk patients who may benefit from more urgent endoscopy.<\/jats:p>","DOI":"10.3389\/fmed.2021.700753","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T14:42:07Z","timestamp":1626964927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The Value of Quantitative Faecal Immunochemical Testing as a Prioritisation Tool for the Endoscopic Investigation of Patients With Iron Deficiency"],"prefix":"10.3389","volume":"8","author":[{"given":"William","family":"Clackett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"B1","volume-title":"Iron Deficiency Anaemia Assessment, Prevention and Control: A Guide for Programme Managers","year":"2001"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/gut.34.8.1102","article-title":"Prospective survey of investigations in outpatients referred with iron deficiency anaemia","volume":"34","author":"McIntyre","year":"1993","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard","year":"2011","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1053\/j.gastro.2020.06.046","article-title":"AGA clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia","volume":"159","author":"Ko","year":"2020","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1053\/j.gastro.2020.06.045","article-title":"AGA Technical review on gastrointestinal evaluation of iron deficiency anemia","volume":"159","author":"Rockey","year":"2020","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3748\/wjg.v25.i19.2383","article-title":"High-risk symptoms and quantitative faecal immunochemical test accuracy: systematic review and meta-analysis","volume":"25","author":"Vieito","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B7","article-title":"NICE Guideline 12","volume-title":"Suspected Cancer: Recognition and Referral","year":"2015"},{"key":"B8","volume-title":"Diagnostics Guidance [DG30]. Quantitative Faecal Immunochemical Tests to Guide Referral for Colorectal Cancer in Primary Care","year":"2017"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/codi.15405.","article-title":"Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care","author":"McSorley","year":"2020","journal-title":"Color Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.dld.2011.08.002","article-title":"Is faecal-immunochemical test useful in patients with iron deficiency anaemia and without overt bleeding?","volume":"43","author":"Cilona","year":"2011","journal-title":"Dig Liver Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3349\/ymj.2017.58.5.910","article-title":"A combination of fecal immunochemical test results and iron deficiency anemia for detection of advanced colorectal neoplasia in asymptomatic men","volume":"58","author":"Kim","year":"2017","journal-title":"Yonsei Med J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1515\/cclm-2019-0203","article-title":"The use of faecal immunochemical testing in the decision making process for the endoscopic investigation of iron deficiency anaemia","volume":"58","author":"Rodriguez-Alonso","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gutjnl-2017-314472.280","article-title":"Can measurement of faecal haemoglobin assist in the assessment of iron deficiency anaemia","volume":"66","author":"Robinson","year":"2017","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.dld.2012.01.019","article-title":"Faecal occult blood test and iron deficiency anaemia","volume":"44","author":"Piperno","year":"2012","journal-title":"Dig Liver Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10620-014-3445-3","article-title":"Advances in fecal occult blood tests: the FIT revolution","volume":"60","author":"Young","year":"2015","journal-title":"Dig Dis Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cgh.2018.01.037","article-title":"Risk of oral and upper gastrointestinal cancers in persons with positive results from a fecal immunochemical test in a colorectal cancer screening program","volume":"16","author":"van der Vlugt","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9072172","article-title":"Positive fecal immunochemical test results are associated with increased risks of esophageal, stomach, and small intestine cancers","volume":"9","author":"Jung","year":"2020","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/flgastro-2013-100386","article-title":"Clinical risk factors for underlying gastrointestinal malignancy in iron deficiency anaemia: the IDIOM study","volume":"5","author":"Silva","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3748\/wjg.v26.i1.70","article-title":"Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: role of faecal immunochemical test","volume":"26","author":"Pin-Vieito","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejim.2019.12.015","article-title":"Prevalence of gastrointestinal malignancy in iron deficiency without anaemia: a systematic review and meta-analysis","volume":"72","author":"Alexandre","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00384-020-03635-6","article-title":"The Impact of COVID-19 pandemic in the colorectal cancer prevention","volume":"35","author":"Del Vecchio Blanco","year":"2020","journal-title":"Int J Colorectal Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"A207","DOI":"10.1136\/gutjnl-2017-314472.403","article-title":"Repeat bi-directional endoscopy for recurrent iron deficiency anaemia\u2014is it worth it?","volume":"2","author":"Rej","year":"2017","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","first-page":"138:S","DOI":"10.1016\/S0016-5085(10)62930-7","article-title":"Follow-up of patients with iron deficiency anemia subsequent to negative upper and lower gastrointestinal investigations","author":"Taylor","year":"2010","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/gut.2008.159723","article-title":"Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis","volume":"57","author":"Ford","year":"2008","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.3399\/bjgp11X572427","article-title":"The diagnostic value of symptoms for colorectal cancer in primary care","volume":"61","author":"Astin","year":"2011","journal-title":"Br J Gen Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/bmj.c1269","article-title":"Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis","volume":"340","author":"Jellema","year":"2010","journal-title":"BMJ"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.700753\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T14:42:13Z","timestamp":1626964933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.700753\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":26,"alternative-id":["10.3389\/fmed.2021.700753"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.700753","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"article-number":"700753"}}